Editorial - (2021) Volume 10, Issue 2

*Correspondence: Professor. YANGCHAO CHEN, The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, Email:

Author info »



The Indian drug industry has filled consistently as of late, as demonstrated by the increment underway, capital creation, and appearance of new parts on the lookout. While the drug area fundamentally affects the Indian economy, overseeing it in the present complex climate has gotten testing. Changes in the worldwide economy, strengthening contest, and developing industry approaches present difficulties for pharma organizations.This article is a selection from the meeting with Mr. Melvin D'Souza, Vice President and General Manager, Novo Nordisk India Pvt Ltd. that clarifies the present status of the Indian drug area, and the deals and dissemination challenges looked by its players.


Over the most recent couple of years, there has been an expanded spotlight by drug organizations on their deals and promoting exercises. The exceptionally cutthroat climate, alongside the accessibility of comparable contending items has made it trying for deals experts to advance the remedy of their items. Generally deals exercises have predominantly focussed on instructing doctors and drug specialists about new items and giving the fundamental data about utilization and advantages. Other than the standard promoting exercises, quite possibly the best manners by which drug organizations have expanded remedy of their items has experienced reception of interesting selling systems by their business power. The drug business, both in India and around the world, has had a long history of utilizing individual selling, and there has been a new sizeable expansion in endeavors to further develop their business association and methodology, thinking about the intricate selling climate.

The adequacy of individual selling ostensibly, changes as per the various ventures, markets and items being referred to, just as the different client types. In drug selling, the salesman gives doctors and drug specialists the most recent data and updates on drugs, and their structure, utilization and advantages. The data is urgent for the two doctors and drug specialists, since the drug business is a unique one. The agent gets input from the doctors about the medication use, which is passed back to the R&D branch of the delegate's organization. The achievement of selling in the drug area to a great extent relies upon the sort of relationship worked with doctors, drug specialists and clinic chairmen. Specifically, the relationship quality and sales rep's ability altogether impact doctors' trust and choices. In this unique circumstance, our meeting intends to distinguish the meaning of individual selling in helping the dynamic cycle of doctors, just as the structure of long haul connections which is vital for the accomplishment of drug organizations.

The Indian drug area

Universally, the drug area has been going through remarkable disturbances in the course of the last decade. While the area has shown generally speaking development in India, the pace of development has been conflicting (Agarwal, Dreszer and Mina, 2017). The enormous drug organizations have shown an unmistakable fascination for growing to provincial India, and along different verticals. The pharma area in India has likewise gone through critical movements and developments.

Organizations in this area have embraced multi-channel deals and advertising models, and techniques to augment the span of their items. The Indian drug industry is unique in relation to the worldwide drug industry.

As per reports by India Brand Equity Foundation (IBEF) 20171, the Indian pharma area is:

• developing at a pace of more than 10–12 % each year, contrasted with 7% yearly development for the world market;

• expected to extend at a CAGR of 22.4%, and arrive at US$55 billion by 2020;

• one of the quickest developing areas in the nation, representing about 1.4% of the worldwide drug industry in esteem terms.

• subject to expanding strain to enhance because of an ascent in patent terminations, powerless pipeline quality and expanding center by governments to diminish medical care costs; and

• positioned fifth on the planet as far as drawing in unfamiliar direct speculation (FDI), with a total progression of USD11.6 billion from 2000–2014.

With regards to the Indian drug area, business techniques that are fitting in the Western setting may not be appropriate in India.2 Further, we can't fight that the Indian drug industry has followed a similar development design as that of the Western nations before.

With the ascent in FDI inflows, there has been an increment in the progression of assets into Indian pharma, and organizations are fostering their development designs as needs be.

Personal selling in the pharmaceutical Industry

Indian pharmaceutical companies have transitioned from conservative sales models to more innovative approaches. This expansion in recent years has led to an increase in the number of global brands and products launched. At the same time, the sales force has been expanding significantly to reach all parts of the country. In a bid to further increase revenues, companies have started to engage in better scientific promotion, and deployment of new and efficient sales force structures to more target markets.4

Pharmaceutical companies have begun to direct their sales force at physicians who make decisions on the prescription of drugs. Approximately 65% of the total spending of pharmaceutical companies has been on their sales force, which in turn provides the latest information about the drugs and plays a major role in the decisions made by physicians as to whether the drug should be prescribed. With the rapid changes in the industry and new drugs continually being developed, physicians need to be continuously updated about products in the industry.


• Drawing in great ability for drug selling has been a significant worry due to generalizing and traditionalist payouts.

• Given the development of deals occupations in data innovation and monetary foundations, this calling has gotten less interesting to the more youthful age.


• It requires almost 6–8 months for salesmen to acquaint themselves with selling methods and get solid client experiences, however they are feeling the squeeze to follow through at work right away.

• Selling channels and exchange can likewise squeeze "moral" norms.


• Utilization of data innovation and devices, for example, iPads and tablets are gradually turning into the standard as drug deals apparatuses, and they empower the catch of ongoing information that could give salesmen, directors and the showcasing group genuinely necessary bits of knowledge.

• These apparatuses can likewise be utilized to comprehend remedy inclinations and patterns.

Human component

• Individual selling by salesmen is the center to "winning" in a business work, and innovation can just assistance as empowering influences to make the job more refined and better.

• There is a requirement for a client or patient-driven methodology in planning promoting and deals exercises.

• It involves greater duty towards customers, patients and society

Author Info

1The Chinese University of Hong Kong, School of Biomedical Sciences, Hong Kong, Hong Kong

Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Get the App